Table 4 Percentage of subjects for each treatment group reporting adverse events
Adverse event | Quetiapine (%, n) | Placebo (%, n) |
|---|---|---|
Sedation | 75% (15) | 33.3%(7) |
Dry mouth | 15% (3) | 0 |
Headache | 15% (3) | 38% (8) |
Fatigue | 15% (3) | 19% (4) |
Irritability | 10% (2) | 4.7% (1) |
Impaired concentration | 10% (2) | 0 |
Dizziness | 5% (1) | 14.3% (3) |
Nausea | 5% (1) | 9.5% (2) |
Increased appetite | 5% (1) | 9.5% (2) |
Delayed ejaculation | 5% (1) | 0 |
Weight gain | 5% (1) | 0 |
Worsening mood | 5%(1) | 4.7%(1) |
Memory difficulties | 5%(1) | 0 |
Muscle aches | 5%(1) | 0 |
Abdominal tenderness | 5%(1) | 0 |
Slurred speech | 5%(1) | 0 |